Drugs / BNT331
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06469164 | Jul 2024 → Jul 2025 | bacterial vaginosis | BioNTech SE | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BNT331 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06469164 ↗ |
| Route | Other | “The vaginal inserts will be self-administered by the participant.” NCT06469164 ↗ |